Existence of β3-adrenoceptors in rat heart: Functional implications

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 8, 2007, Pages 796-798

  Barbier, J ^a,c   Mouas, C ^b   Rannou Bekono, F ^a   Carre F ^c  

^a UNIVERSITÉ RENNES 2   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

3 adrenoceptor; Isolated perfused heart; Left ventricular function

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HEART; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; INOTROPISM; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; HEART; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PROPANOLAMINES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-3; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 34347329112     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04633.x     Document Type: Article

References (12)

1. Steinberg SF. The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ. Res. 1999 85 : 1101 11.
2. Berlan M, Galitzky J, Bouquet-Melou A, Lafontan M, Montastruc JL. Beta3-adrenoceptor mediated increase in cutaneous blood flow in the dog. J. Pharmacol. Exp. Ther. 1994 268 : 144 51.
3. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional β3-adrenoceptor in the human heart. J. Clin. Invest. 1996 98 : 556 62.
4. Gauthier C, Tavernier G, Trochu JN et al. Interspecies differences in the cardiac negative inotropic effects of β3-adrenoceptor agonists. J. Pharmacol. Exp. Ther. 1999 290 : 687 93.
5. Kitamura T, Orishi K, Dohi K, Okinaka T, Isoka N, Nakano T. The negative inotropic effect of β3 adrenoceptor stimulation in the beating guinea pig heart. J. Cardiovasc. Pharmacol. 2000 35 : 786 90.
6. Rozec B, Noireaud J, Trochu JN, Gauthier C. Place of β3-adrenoceptor subtypes in the regulation of the cardiac vascular system. Cardiovasc. Res. 2003 96 : 905 13.
7. Takayama S, Furukawa Y, Ren L-M, Inoue S, Sawaki S, Chiba S. Positive chrontropic and inotropic responses to BRL 3 7344, a β3-adrenoreceptor agonist in isolated, blood-perfused dog atria. Eur. J. Pharmacol. 1993 231 : 315 21.
8. Tavernier G, Toumaniantz G, Erfanian M et al. β3-adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human β3-adrenergic receptor. Cardiovasc. Res. 2003 59 : 288 96.
9. Wheeldon NM, McDevitt DG, Lipworth BJ. Investigation of putative cardiac β3-adrenoceptors in man. Q. J. Med. 1993 86 : 255 61.
10. Langendorff O. Untersuchungen am uberlebenden saugethierherzen. Pflügers Arch. Gesamte Physiol. Menschen Tiere 1895 61 : 261 332.
11. Gauthier C, Leblais V, Kobsiky L et al. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 1998 102 : 1377 84.
12. Rohrer DK, Chruscinski A, Schauble EH, Bernstein D, Kobilka BK. Cardiovascular and metabolic alterations in mice lacking both beta1 and beta2 adrenergic receptors. J. Biol. Chem. 1999 274 : 16 01 8.